Skip to main content
Log in

Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

We reviewed the records of 315 patients with rheumatoid arthritis (RA) treated with low-dose methotrexate (MTX) and evaluated the conditions contributing to thrombocytopenia. Thirteen out of 315 patients with RA presented with low platelet counts (≤100.000/mm3). The age of these patients (51 ± 12.6 years) did not correlate with thrombocytopenia (r=0.211, p>0.05).

Thrombocytopenia resulted from coadministration of MTX and NSAID or multiple drug interactions. We observed a significant (r=0.48, p<0.05) increase of discontinuation of NSAID's but not of MTX therapy (r=0.42, p>0.05) with a mounting weekly dosage of MTX (12.5±5 mg orally). There was a significant correlation between this weekly dosage of MTX coadministered on the same day with NSAID and thrombocytopenia (r=0.6, p<0.05).

In most cases (9/13) MTX was not or just temporarily withdrawn. Three of the remaining patients had multiple drug interactions. Reintroduction of low dose MTX treatment in patients having had thrombocytopenia could be performed safely, if thrombocytopenia occurred as a result of concomitant application of MTX and NSAID and no other multiple drug interactions. Preferably, MTX and NSAID should be given to these risk patients on separate days or intervals considering half time clearance of NSAIDs. This procedure has prevented the reoccurrence of thrombocytopenia and controlled further drug interactions of NSAIDs and MTX in our patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Willkens, R.F., Watson, M.A., Paxson, C.S. Low dose pulse methotrexate therapy in rheumatoid arthritis. J Rheumatol 1980, 7, 501–505.

    PubMed  Google Scholar 

  2. Steinsson, K., Weistein, A., Korn, J., Abeles, M. Low dose methotrexate in rheumatoid arthritis. J Rheumatol 1982, 9, 860–866.

    PubMed  Google Scholar 

  3. Anderson, P.A., West S.G., O'Dell, J.R., Via, C.S., Claypool, R.G., Kotzin, B.L. Weekly pulse methotrexate in rheumatoid arthritis: clinical and immunologic effects in a randomized, double-blind study. Ann Intern Med 103, 1985, 489–496.

    PubMed  Google Scholar 

  4. Weinblatt, M.E., Weissman, B.N., Holdsworth, D.E., Fraser, P.A., Maier, A.L., Falchuk, K.R., Coblyn, J.S. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. Arthritis and Rheumatism 1992, 35 (2) 129–137.

    PubMed  Google Scholar 

  5. Rau, R., Karger, T., Herborn, G., Frenzel, H. Liver biopsy findings in patients with rheumatoid arthritis undergoing long-term treatment with methotrexate. J Rheumatol 1989, 16, 489–493.

    PubMed  Google Scholar 

  6. Robes, M.W., Bennett, G.A., Cobb, S., Jacox, R., Jessar, R.A. 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Diss 1958, 175–176

  7. Edelman, J., Russel, A.S., Biggs, D.F. Methotrexate levels a guide of therapy? Clin Exp Rheum 1983, 1, 153–156.

    Google Scholar 

  8. MacKinnon, S.K., Starkebaum, G., Willkens, R. Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis. Arthritis Rheum 1985, 15, 119–126

    Google Scholar 

  9. Malprin, K.M., Fukui, D., Ohkawara A. Blood levels of methotrexate and the treatment of psoriasis. Arch Dermatol 1971, 103, 243–249.

    PubMed  Google Scholar 

  10. Ferrazzini, G., Klein, J., Sulh, H. et al. Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia. J Pediatr 1990, 117, 823–826.

    PubMed  Google Scholar 

  11. Groenendal, H., Rampen, F.H.J. Methotrexate and trimethoprim- sulphamethoxazole — a potentially hazardous combination. Clin Exp Dermatol 1990, 15, 358–360

    PubMed  Google Scholar 

  12. Al-Awadhi, A., Dale, P., McKendry, R.J. Pancytopenia associated with low dose methotrexate therapy. A regional survey. J Rheumatol 1993, 20(7), 1121–1125.

    PubMed  Google Scholar 

  13. Alarcón, G.S., Tracy, I.C., Blackburn, D. Methotrexate in rheumatoid arthritis. Toxic effect as the major factor in limiting long-term treatment. Arthritis Rheum 1989, 32, 671–676.

    PubMed  Google Scholar 

  14. Rooney, T.W., Furst, D.E. Comparison of toxicity in methotrexate treated rheumatoid arthritis patients also taking aspirin or other NSAID (abstract). Arthritis Rheum 1986, 29(4), 76

    Google Scholar 

  15. Shupack, J.L., Webster, G.F. Pancytopenia following low-dose oral methotrexate therapy for psoriasis. JAMA 1988, 259, 3594–3596.

    PubMed  Google Scholar 

  16. Kevat, S.G., McCarthy, P.J., Hill, W.R. et al. Pancytopenia induced by low-dose methotrexate for rheumatoid arthritis. Aust NZ J Med 1988, 18, 697–700.

    Google Scholar 

  17. Furst, D.E., Herman, R.A., Koehnke, R. et al. Effect of aspirin and sulindac on methotrexate clearance. J Pharm Sci 1990, 79, 782–786.

    PubMed  Google Scholar 

  18. Clive, D.M., Stoff, J.S. Renal syndromex associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984, 310, 563–572.

    PubMed  Google Scholar 

  19. Steele, W.H., Lawrence, J.R., Stuart, J.F.B. The protein binding of methotrexate by the serum of normal subjects. Eur J Clin Pharmacol 1979, 15, 363–366.

    PubMed  Google Scholar 

  20. Claudepierre, P., Urien, S., Chevalier, X., Chassany, O., Larget-Piet, B., Tillement, J.P. Methotrexate serum binding in rheumatoid arthritis. Int J Clin Pharmacol Ther 1994, 32(3), 113–115.

    PubMed  Google Scholar 

  21. Bannwarth, B., Labat, L., Moride, Y., Schaeverbeke, T. Methotrexate in rheumatoid arthritis. An update. Drugs. 1994, 47(1), 25–50.

    Google Scholar 

  22. Frenia, M.L., Long, K.S. Methotrexate and nonsteroidal anti-inflammatory drug interactions. Ann Pharmacother 1992, 26(2), 234–237.

    PubMed  Google Scholar 

  23. Stewart, F., Fleming, R.A., Arkin et al. Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis. Clin Pharmacol Ther 1990, 47, 540–546.

    PubMed  Google Scholar 

  24. Tracy, T.S., Krohn, K., Jones, D.R., Bradley, J.D., Hall, S.D., Brater, D.C. The effects of salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis. Eur J Clin Pharmacol 1992, 42(2), 121–125.

    PubMed  Google Scholar 

  25. Tracy, T.S., Worster, T., Bradley, J.D., Greene, P.K., Brater, D.C. Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis. Br J Clin Pharmacol 1994, 37(5), 453–456.

    PubMed  Google Scholar 

  26. Steinbrocker, O. Criteria in rheumatoid arthritis. JAMA 1949, 140, 659–662

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Franck, H., Rau, R. & Herborn, G. Thrombocytopenia in patients with rheumatoid arthritis on long-term treatment with low dose methotrexate. Clin Rheumatol 15, 266–270 (1996). https://doi.org/10.1007/BF02229705

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02229705

Key words

Navigation